If you have a meticulous skincare routine, you know that personal skincare products (PSCPs) are a big business.
Novartis shares updated data for BTK inhibitor; Astellas resubmits BLA for cancer drug after CRL
Plus, news about Valar Labs, Pharming Group and Day One Pharmaceuticals: Novartis outlines one-year data for BTK inhibitor: The drug, called remibrutinib, Sign up to